Table 1.
Study population and sampling time.
Population | |
---|---|
Number of subjects included | 53 |
Median age and range (years) | 63 (38–71) |
Male/female | 17/36 |
Vaccination | |
First dose of vaccine | January 2021 |
Second dose of vaccine | February 2021 |
Third dose of vaccine (booster dose) | October 2021 |
Sampling | |
First sampling (T1) | March 2021 |
Second sampling (T2) | September 2021 |
Third sampling (T3) | November 2021 |
End of the monitoring | May 2022 |